Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp Ads (NQ: AMRN )

5.058 USD +0.218 (+4.51%)
Streaming Delayed Price Updated: 11:30 AM EST, Dec 3, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,813,230
Open 4.840
Bid (Size) 5.050 (41)
Ask (Size) 5.060 (96)
Prev. Close 4.840
Today's Range 4.840 - 5.060
52wk Range 3.360 - 26.12
Shares Outstanding 293,584,140
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amarin Files Patent Infringement Lawsuit Against Hikma
From GlobeNewswire News Releases
Amarin to Present at Piper Sandler’s 32nd Annual Healthcare Conference (Virtual)
From GlobeNewswire News Releases

Performance

YTD
-76.51%
-76.51%
1 Month
+2.40%
+2.40%
3 Month
+0.37%
+0.37%
6 Month
-23.82%
-23.82%
1 Year
-76.61%
-76.61%

More News

Read More
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
From GlobeNewswire News Releases
Multiple New VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association’s Virtual Scientific Sessions 2020
From GlobeNewswire News Releases
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® S
From GlobeNewswire News Releases
Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences
From GlobeNewswire News Releases
With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
With Growing Incidence of Brain Cancer The Brain Tumor Drug Market Could Reach $3.4 Billion in 2022
From PR Newswire
Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
More Comprehensive Diagnostics are Needed as Cases Surge Once More
From PR Newswire
ROCE Insights For Amarin Corp
Tags News Earnings Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.